The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

Clalit Health Services

Status: Withdrawn

Conditions: Preeclampsia; Pregnancy

Study type: Observational

Funder types: Other

Identifiers

NCT01179542

mmc10134-2010ctil

Details and patient eligibility

About

The involvement of eukaryotic translation initiation factor 4E (eIF4E) in human placental implantation and in the pathological pregnancies: preeclampsia and IUGR.

Full description

4 groups

Sex: Female

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• post TOP or DELIVERY

Exclusion criteria

Trial design

0 participants in 4 patient groups

first trimester

Description:

first trimester

third trimester

Description:

third trimester

prgnancies complicated with IUGR

Description:

prgnancies complicated with IUGR

preeclampsia

Description:

preeclampsia